Selecta Russia

Для того, чтобы увидеть эту страницу на русском языке, нажмите здесь

SELECTA(RUS) is a wholly owned subsidiary of Selecta Biosciences, Inc. and is located in Moscow, Russia. SELECTA(RUS) is building a pipeline of targeted immunotherapies and vaccines in the areas of oncology and infectious diseases based on Synthetic Vaccine Particles (SVP™). Our activities in Russia aim at expanding Selecta’s portfolio of immunotherapies. SELECTA(RUS)’s R&D programs are developed in close coordination with Selecta’s leadership team in Boston, Massachusetts.


Back to Top